Clinical trial

Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral…

NCT00027820 · Fred Hutchinson Cancer Center, Other · Completed

Key facts

NCT number NCT00027820
Title Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer
Official title Low-Dose TBI and Fludarabine Followed by Nonmyeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation Using Enhanced Postgrafting Immunosuppression for Patients With Hematologic Malignancies and Renal Cell Carcinoma - A Multi-center Trial
Lead sponsor Fred Hutchinson Cancer Center, Other
Collaborators National Heart, Lung, and Blood Institute (NHLBI) NIH National Cancer Institute (NCI)
Status Completed
Phase Phase 1/Phase 2
Study type Interventional
Conditions Adult Acute Myeloid Leukemia in Remission, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Myelodysplastic Syndrome, Childhood Renal Cell Carcinoma, Chronic Myelomonocytic Leukemia, Clear Cell Renal Cell Carcinoma, de Novo Myelodysplastic Syndrome, Metastatic Renal Cell Cancer, Previously Treated Myelodysplastic Syndrome and 20 more
Intervention type Drug, Procedure, Radiation
Interventions Fludarabine Phosphate, Total-Body Irradiation, Peripheral Blood Stem Cell Transplantation, Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation, Cyclosporine, Mycophenolate Mofetil
Enrollment 106
Start date Aug 1, 2001
Primary completion Sep 1, 2004
Completion Sep 5, 2004
First posted Jan 27, 2003
Last update posted Dec 20, 2019
Countries Germany, Italy, United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies